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Background: Probiotics are an upcoming group of nutraceuticals claiming positive effects on athlete’s gut health,
redox biology and immunity but there is lack of evidence to support these statements.
Methods: We conducted a randomized, double-blinded, placebo controlled trial to observe effects of probiotic
supplementation on markers of intestinal barrier, oxidation and inflammation, at rest and after intense exercise. 23
trained men received multi-species probiotics (1010 CFU/day, EcologicWPerformance or OMNi-BiOTiCWPOWER,
n = 11) or placebo (n = 12) for 14 weeks and performed an intense cycle ergometry over 90 minutes at baseline and
after 14 weeks. Zonulin and α1-antitrypsin were measured from feces to estimate gut leakage at baseline and at the
end of treatment. Venous blood was collected at baseline and after 14 weeks, before and immediately post
exercise, to determine carbonyl proteins (CP), malondialdehyde (MDA), total oxidation status of lipids (TOS), tumor
necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). Statistical analysis used multifactorial analysis of variance
(ANOVA). Level of significance was set at p < 0.05, a trend at p < 0.1.
Results: Zonulin decreased with supplementation from values slightly above normal into normal ranges
(<30 ng/ml) and was significantly lower after 14 weeks with probiotics compared to placebo (p = 0.019). We
observed no influence on α1-antitrypsin (p > 0.1). CP increased significantly from pre to post exercise in both
groups at baseline and in the placebo group after 14 weeks of treatment (p = 0.006). After 14 weeks, CP
concentrations were tendentially lower with probiotics (p = 0.061). TOS was slightly increased above normal in both
groups, at baseline and after 14 weeks of treatment. There was no effect of supplementation or exercise on TOS. At
baseline, both groups showed considerably higher TNF-α concentrations than normal. After 14 weeks TNF-α was
tendentially lower in the supplemented group (p = 0.054). IL-6 increased significantly from pre to post exercise in
both groups (p = 0.001), but supplementation had no effect. MDA was not influenced, neither by supplementation
nor by exercise.
Conclusions: The probiotic treatment decreased Zonulin in feces, a marker indicating enhanced gut permeability.
Moreover, probiotic supplementation beneficially affected TNF-α and exercise induced protein oxidation. These
results demonstrate promising benefits for probiotic use in trained men.
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Probiotic bacteria are described as live microorganisms
that beneficially modulate microbiota and health of the
host [1]. In the last few years they became increasingly
popular as nutritional supplements especially to achieve
reduction of gastrointestinal (GI) complaints and com-
mon infectious illnesses. In sports and exercise, there is
some evidence for probiotics’ potential to reduce inci-
dence and severity of respiratory tract infections [2,3],
and to shorten the duration of GI symptoms in trained
athletes [4]. Other studies report attenuation of exercise-
induced increase in pro- and antiinflammatory cytokines
after 11 weeks [5] and increased plasma antioxidant
levels after 4 weeks of probiotic supplementation [6].
In performance sports there is a high prevalence of GI
complaints among endurance athletes like runners and
triathletes [7]. These problems are attributed to changed
blood flow, that is shunted from the viscera to skeletal
muscle or the heart [8]. Such exercise-induced reduc-
tions in intestinal blood flow as well as exercise-linked
thermal damage to the intestinal mucosa can cause in-
testinal barrier disruption, followed by an inflammatory
response [9]. Symptoms described are nausea, stomach
and intestinal cramps, vomiting and diarrhea. The
increased permeability of the instesinal wall leads to
endotoxemia, and results in increased susceptibility to
infectious- and autoimmune diseases, due to absorption of
pathogens/toxins into tissue and blood stream [10-12].
Thus, to reduce exercise-induced GI permeability and its
associated symptoms and illnesses, nutritional solutions
like probiotic supplementation may be of relevance for
athletes and also a real challenge for the probiotic industry
to develop bioeffective products.
Tight junctions are protein structures that represent
the major barrier within the intestinal paracellular path-
way. They seal the paracellular space between epithelial
cells and regulate the movement of fluid, macromole-
cules and leukocytes between the bloodstream and the
intestinal lumen, and vice versa [13]. These complex
structures consist of more than 50 proteins and are
regarded to be key factors of GI permeability [14].
Commensal and probiotic strains modulate the amount
of tight junction proteins at the cell boundaries and can
prevent or reverse adverse effects of pathogens. Several
probiotic strains such as Lactobacillus plantarum
[15-17], Bacteroides thetaiotaomicron ATCC29184
[18], Escherichia coli Nissle 1917 [19], Bifidobacter-
ium longum SP 07/3 and Lactobacillus rhamnosus
GG [20] revealed beneficial impacts on tight junction-
and intestinal barrier function. Moreover, various
dietary components like polyphenols, proteins or
amino acids are postulated to regulate epithelial per-
meability by modifying expression and localization of
tight junction proteins in the paracellular space [14].Zonulin - a protein of the haptoglobin family released
from liver and intestinal epithelial cells - is described as
the main physiological modulator of intercellular tight
junctions so far. Increased zonulin concentrations are
related to changes in tight junction competency and
increased GI permeability [21]. The “leak” in the para-
cellular absorption route enables antigens to pass from
the intestinal milieau, challenging the immune system to
produce an immune response and subsequent inflamma-
tion and oxidative stress [13,22,23].
The effects of probiotics on GI barrier integrity, inflam-
mation and oxidative stress, are not elucidated particularly
in the context of sports and exercise. Hence, we focussed
the primary outcome of this study to explore the effects of
a multi-species probiotic supplement on GI permeability
in endurance trained men. The secondary outcome of this
trial was to evaluate whether the probiotic supplementa-
tion affects markers of oxidation and inflammation in
plasma, before and after intense exercise.
Methods
Subjects
23 endurance trained men (triathletes, runners, cyclists)
participated in this trial. Inclusion criteria: male, healthy,
30–45 years, non-smokers, trained (maximum oxygen
uptake, VO2max > 45 mL
. kg-1 . min-1), no dietary or nu-
tritional supplement use within four weeks prior to the
first exercise test. Exclusion criteria: smokers, men who
failed eligibility testing for exercise - as described by the
Austrian and German standards in sports medicine [24],
men who significantly changed training regimen during
the study, chronic or excessive alcohol consumption, re-
cent surgery or illness, body fat > 20%. Body fat content
and distribution was estimated by a computerized op-
tical device Lipometer (Möller Messtechnik, Graz,
Austria), as described by Möller, et al. [25]. Besides in-
clusion and exclusion criteria, a standard blood chemis-
try panel was determined after an overnight fast and all
subjects completed a medical history. Subjects character-
istics are presented in Table 1.
Ethical aspects, recruitment and randomization
All subjects provided written informed consent prior to
participating in this investigation. This study was con-
ducted according to the guidelines of the Declaration of
Helsinki for Research on Human Subjects 1989 and was
approved by the Ethical Review Committee of the Medical
University of Graz, Austria. The trial was registered under
www.clinicaltrials.gov, identifier: NCT01474629.
The study focused trained men and was advertised in
the largest sports magazine of Austria. After a telephone
screening conducted by the research team, 29 men
volunteered for eligibility testing. From those, 24 men
were eligible and entered the study program.
Table 1 Baseline characteristics, performance data, clinical chemistry and nutrition data of 23 trained men1
Variable Reference range2,3 Probiotics (n = 11) Placebo (n = 12)
Age, yr 37.6 ± 4.7 38.2 ± 4.4
BMI, kg . m-2 23.7 ± 2.2 23.9 ± 3.1
Weight, kg 80.2 ± 7.9 81.6 ± 6.3
Total body fat, % 14.2 ± 3.1 14.4 ± 3.5
VO2max, mL 4118± 172 4087± 169
VO2max, mL
. kg-1 . min-1 51.2 ± 4.1 50.3 ± 3.6
Pmax, W 367± 28 357± 32
Prel, W
. kg-1 4.53 ± 0.55 4.38 ± 0.62
Clinical Chemistry:
Glucose, mmol . L-1 3.9–6.1 4.5 ± 0.5 4.7 ± 0.4
Hemoglobin, g . L-1 136–172 153± 12 155± 19
Iron, μmol . L-1 14–32 20.4 ± 4.5 18.6 ± 3.9
Ferritin, μg . L-1 18–300 101± 42 89 ± 36
Cholesterol, mmol . L-1 < 5.85 4.47 ± 1.23 4.56 ± 1.13
HDL, mmol . L-1 0.80–1.80 1.30 ± 0.13 1.33 ± 0.19
Triglycerides, mmol . L-1 < 1.80 0.87 ± 0.32 0.81 ± 0.36
Vitamin D3, nmol
. L-1 75–250 98 ± 26 106± 31
Testosterone, nmol . L-1 10–31 16.3 ± 4.9 18.2 ± 4.1
Creatinine, μmol . L-1 50–110 87 ± 13 93 ± 19
Diet (exerpts):
Energy, kJ . d-1 11776–13902 11989± 1803 12356± 2455
Fat, % < 30% of kJ  d-1 34.5 ± 6.2% 35.9 ± 5.1%
Protein, % 10–15% of kJ  d-1 14.7 ± 2.1% 15.8 ± 3.2%
Carbohydrates, % > 50% of kJ  d-1 47.9 ± 9.1% 46.5 ± 10.3%
Alcohol, % < 3.5% 1.9 ± 1.2% 1.5 ± 0.9%
Water, mL 2600 3162± 595 3022± 952
Fibres, g 30 23 ± 7 21± 6
Vitamin C, mg 72–106 113± 58 118± 66
Vitamin E, mg 14 12 ± 5 15± 9
ß-Carotene, mg 4 3.1 ± 2.5 3.2 ± 2.7
Folate, μg 434–505 281± 155 244± 165
Vitamin B-6, mg 3.2–3.8 5.3 ± 2.9 5.1 ± 2.8
Vitamin B-12, μg 3.3–3.7 5.0 ± 2.8 5.8 ± 1.4
Sodium, mg > 646 2610± 685 2446± 770
Potassium, mg 2171–2523 3162± 904 3406± 1251
Magnesium, mg 185–361 412± 134 444± 119
Calcium, mg 1085–1261 1108± 395 998± 327
Iron, mg 10.9–12.5 13.3 ± 4.6 14.5 ± 6.2
1Values are means ± SD, and did not differ between the groups (P > 0.05, Student’s t-test); 2Reference range for clinical chemistry parameters [26]; 3Reference
values for dietary intake (RDA) in Germany, Austria, Switzerland [27], ranges presented here apply to physical active people; VO2max =maximum oxygen uptake,
Pmax =maximum performance, Prel = Performance related to body weight.
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sequentially numbered. To guarantee a balanced
VO2max distribution between groups (probiotics versus
placebo) we conducted stratification via VO2max rankstatistics. Randomization code was held by a third
party (Union of Sport and Exercise Scientists Austria)
and handed over for statistical analyses after collec-
tion of all data.
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This was a randomized, placebo controlled, double-
blinded study. All eligibility testing (blood panel,
eligibility for exercise, clinic check-up, medical history
questionaire, one-on-one interview) was finalized at least
four weeks prior to the first exercise test. At the morn-
ing of the first exercise test a standardized breakfast
(3 hours prior to exercise) was provided. After the test,
the investigator dispensed the randomized sachet supply
according to the man’s VO2max-ranking. After 14 weeks
taking the powder from sachets as directed, they
returned their remaining sachets and the same test pro-
cedure was repeated. All subjects were checked by the
physician before each exercise test.
Dietary and lifestyle assessment
Subjects were instructed to maintain their habitual diet,
lifestyle and training regimen during the fourteen weeks
study and to duplicate their diet before each exercise
testing/blood collection appointment as described below.
Before the first triple step test, men completed a 7-day
food record for nutrient intake assessment. Subjects sub-
sequently received copies of their 7-day diet records and
were instructed to replicate the diet prior to the second
exercise tests. The breakfast before each exercise test
was standardized for the entire cohort to limit nutrient
variation due to self-selection on the morning scheduled
for blood draws. The composition of this standardized
breakfast 3 hours prior to the strenuous exercise tests is
shown in Table 2. Diet records were analyzed for total
calories, protein, carbohydrate, fat, cholesterol, fiber,
water, alcohol, and several vitamins, minerals, and fatty
acids using “opti diet” software 5.0 (GOEmbH, Linden,
Germany).
Treatment
The men randomized to probiotics (n = 11) received
boxes with sachets containing multi-species probiotics
(EcologicWPerformance, produced by Winclove b.v.,Table 2 Composition of the standardized breakfast 3 hours p
Food kJ
Coffee with milk (low fat) or Tea with lemon and honey (10g) 180
3 slices wheat or rye bread 139
Butter 20 g 652
Marmalade/jam 30 g 343
One slice low fat ham 331
One piece of cheese 490
250 mL fruit juice 836
250 mL water -
Total 422
Meal energy %Amsterdam, the Netherlands; the product is also
branded as OMNi-BiOTiCWPOWER). The probiotic
supplement contained of a matrix and six probiotic
strains: Bifidobacterium bifidum W23, Bifidobacterium
lactis W51, Enterococcus faecium W54, Lactobacillus
acidophilus W22, Lactobacillus brevis W63, and Lacto-
coccus lactis W58. The matrix consisted of cornstarch,
maltodextrin, vegetable protein, MgSO4, MnSO4 and
KCl. The placebo consisted of the matrix only. The
minimum concentration was 2.5 × 109 colony forming
units (CFU) per gram. Subjects were instructed to take 2
sachets a 2 g per day (4 g/day), equivalent to 1010 CFU/
day, with 100–125 mL of plain water per sachet, one
hour prior to meals and throughout 14 weeks. Those
subjects randomized to placebo (n = 12) received identi-
cal boxes and sachets with the same instructions for
intake.
Exercise tests
Each subject was instructed not to perform physical
training 3 days prior to any exercise test.
For eligibility testing all subjects performed an incre-
mental cycle ergometer exercise test (EC 3000, Custo
med GmbH, Ottobrunn, Germany) at 80 rpm. After a
three minute rest phase sitting inactive on the ergom-
eter, work rate started at 60 W for three minutes and
was increased 20 W every minute until voluntary ex-
haustion. This allowed subjects to reach exhaustion
within 15–18 minutes. A standard electrocardiogram
was recorded during the entire test, which was super-
vised by a physician. Respiratory gas exchange variables
were measured throughout the incremental exercise
tests using a breath-by-breath mode (Metalyzer 3B,
Cortex Biophysik GmbH, Leipzig, Germany). During
these tests, subjects breathed through a facemask.
Oxygen uptake (VO2), carbon dioxide output (VCO2),
minute ventilation (VE), breathing rate (BR) and tidal
volume (VT) were continuously obtained. Heart rate
(HR) was monitored throughout the tests using arior to the strenuous triple step test ergometry
Protein (g) Fat (g) Carbohydrates (g)
0-2 0-2 4-10







2 32-34 28-30 144-150
13% 27% 60%
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NV, Polar Electro Finland).
For the triple step test ergometry we used the same
test protocol as described above but repeated the incre-
mental exercise test for two times, so that three step
tests until voluntary exhaustion were integrated in one
single bout of exercise. After the first and second part of
this triple test subjects performed for 15 minutes with
60 W at 80 rpm. After the third part subjects continued
exercise for three minutes with 60 W and 80 rmp and
stopped then. The whole test procedure lasted between
80 and 90 minutes, depending on duration of each step
test/part.
Blood pressure was controlled after each 100 W and
after the last step of each ergometry. Gas exchange vari-
ables were monitored continuously throughout the step
tests as described above. During the 15 minutes intervals
between the ergometry step tests the facemask was
removed to consume 750 mL of plain water, in total over
the whole test procedure.
Fourteen weeks later this procedure was repeated on
the same cycle ergometer, with the same investigator,
standardized room temperature (20°C) and humidity
(60%).
Blood and feces collection
We conducted blood collections in supine position from
a medial cubital vein at each triple ergometry test: before
exercise (Pre) and within 10 min post exercise (Post).
Venous blood was collected to determine carbonyl pro-
teins (CP), malondialdehyde (MDA), total oxidation sta-
tus of lipids (TOS), tumor necrosis factor-alpha (TNF-α),
and interleukin-6 (IL-6). After centrifugation for 10 minutes
plasma was removed and samples were frozen at −70°C
until analysis.
For zonulin and α1-antitrypsin from feces the subjects
collected samples at baseline and after 14 weeks with
standardized stool tubules within 24 hours prior to
bringing the sample in a cool bag to the laboratory. All
samples were analyzed within 72 hours after dispensing.
Throughout the 14 weeks treatment the subjects
recorded a stool protocol to monitor stool appearance
with help of the Bristol stool scale/chart [28].
Stool analyses
Zonulin and α1-antitrypsin were analyzed with commer-
cially available ELISA kits (Immundiagnostik AG,
Bensheim, Germany).
The zonulin analysis is based on a competition be-
tween the free antigen in the samples or standards and
the antigen coated on the wells of the microplate. Stan-
dards, samples and the primary anti-zonulin antibody
are transferred directly into the precoated microplate
wells. The antigen in the samples competes with theantigen immobilized on the wells of the microplate for
the binding sites of the specific anti-zonulin antibody. A
peroxidase-conjugated antibody is used for detection,
and tetramethylbenzidine as a peroxidase substrate. The
enzymatic reaction is terminated by acidic stop solution.
The quantification is based on the optical density at
450 nm. Data are expressed in ng/mL.
The assay for analyses of α1-antitrypsin utilizes the
“sandwich” technique with two selected polyclonal anti-
bodies that bind to the glycoprotein forming a “sand-
wich” of capture antibody - human α1-antitrypsin -
peroxidase-conjugate. Tetramethylbenzidine is used as
peroxidase substrate. Finally, an acidic stop solution is
added to terminate the reaction. The colour changes
from blue to yellow. The intensity of the yellow colour is
directly proportional to the concentration of α1-anti-
trypsin. Samples are quantified by referring their optical
density to a lot-dependant master calibration curve and
the use of a calibrator that is run with each test. Data
are expressed in mg/dL.
Analyses of blood parameters
CP was analyzed with a commercially available ELISA
(Immundiagnostik AG, Bensheim, Germany) via reaction
of protein with dinitrophenylhydrazine (DNPH). The non-
protein constituents and unconjugated DNPH are sepa-
rated by ultracentrifugation. The proteins are adsorbed to
an ELISA plate and incubated with anti-DNPH antibody
followed by antibody-linked horseradish peroxidase.
Absorbances are related to a standard curve prepared with
oxidized serum albumin. The carbonyl protein content is
calculated from the estimated carbonyl concentration and
the total protein content of the sample. For this reason, a
parallel determination of the protein content is required.
Data are expressed in pmol/mg.
MDA was determined according to a previously
described HPLC method by Pilz et al. [29] after derivati-
zation with 2,4-DNPH. This method determines the
protein bound MDA. The HPLC separations were per-
formed with an L-2200 autosampler, a L-2130 HTA
pump and a L-2450 diode array detector (all: VWR
Hitachi Vienna; Austria). Detector signals (absorbance at
310 nm) were recorded and program EZchrom Elite
(VWR) was used for data requisition and analysis. Data
are expressed in nmol/mL.
Analysis of TOS: This assay (Immundiagnostik AG,
Bensheim, Germany) determines total lipid peroxides
and is performed by the reaction of a peroxidase with
the peroxides in the sample followed by the conversion
of tetramethylbenzidine to a colored product. After
addition of a stop solution the samples are measured at
450 nm in a microtiter plate reader. The quantification
is performed by the delivered calibrator. Data are
expressed in μmol/L H2O2.
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(Immundiagnostik AG, Bensheim, Germany) allowed quan-
titative determination of Tumor Necrosis Factor-α by using
monoclonal antibodies and a horseradish peroxidase la-
beled conjugate. The amount of the converted substrate by
the peroxidase is directly proportional to the amount of
bound TNF-α and can be determined photometrically.
Data are expressed in pg/mL.
IL-6 was also measured with commercial available
ELISA kits (Invitrogen, LifeTech Austria, Vienna, Austria)
using monoclonal antibodies specific for human IL-6.
Based on the binding of streptavidin-peroxidase to anti-
bodies the intensity of a colored adduct is directly propor-
tional to the concentration of the cytokine and can be
determined photometrically. Data are expressed in pg/mL.
Blood chemistry panel
Standard blood chemistry values were determined after
overnight fast using EDTA plasma from peripheral
venous blood. Analyses were conducted with a routine
clinical chemistry analyzer (Abbott Diagnostics, Vienna,
Austria).
Statistical analyses and sample size calculation
Per protocol analyses were performed using SPSS for
Windows software, version 19.0. Data are presented as
mean ± SD. Data for pre - post comparisons were adjusted
for plasma volume changes as described elsewhere (except
for CP, as it is expressed on protein) [30]. Statistical signifi-
cance was set at P<0.05. The Shapiro-Wilk test was used
to determine normal distribution. Baseline characteristics,
performance data, nutrient and clinical chemistry data,
were compared by unpaired Student’s t-test. Data obtained
for CP, MDA, TOS, TNF-α, and IL-6, were analyzed using
a univariate, three-factorial, repeated measures ANOVA.
Factors: treatment (probiotic supplementation and pla-
cebo), exercise (pre and post exercise), session (triple step
test ergometry 1 and triple step test ergometry 2). For
zonulin and α1-antitrypsin we used a two-factorial ANOVA
(treatment, time). Significant interactions and main effects
were analyzed by using Bonferroni correction.
Sample size calculation was based on oxidation markers
CP and MDA. We estimated between 7 and 9 subjects per
group - depending on parameter, standard deviation and
effect size - to reach a probability of error (alpha/2) of 5%
and 80% power. Allowing for a drop-out rate of 30%, 12
subjects per group were recruited.
Results
Study population and nutrition
A CONSORT diagram outlining participant recruit-
ment is depicted Figure 1. Of the 24 randomized
men, 23 completed the full program and entered stat-
istical analyses. There was one early termination inthe probiotic group (n = 11). The man dropped out
due to bone injury unrelated to the study.
Returned sachets count after the treatment period
revealed a compliance >90% in both groups. Groups did
not differ in age, BMI, body weight and fat, clinical
blood chemistry variables, and diet (P > 0.05).Triple cycle step test ergometry
Performance data for VO2max, VO2max related to body
weight (relVO2max), maximum performance and per-
formance related to body weight (Prel) are shown in
Table 1. There were no significant differences be-
tween probiotic supplementation and placebo for
these parameters (P > 0.05).Zonulin
As zonulin was determined from feces we can only
provide values from the last stool prior to exercise.
The mean concentrations of zonulin were at baseline
slightly above normal in both groups (ref. range:
< 30 ng . mL-1, Figure 2). After 14 weeks supplemen-
tation with the multi-species probiotic supplement
zonulin decreased into a normal physiological range
and was significantly lower in the probiotic group
compared to placebo (P = 0.019), this was correspond-
ing to a decrease > 20%.α1-antitrypsin
There were no differences between groups at any
time point assessed, neither with treatment nor with
exercise. α1-antitrypsin concentrations in feces were
within normal range at baseline and after 14 weeks of
treatment (< 27.5 mg . dL-1, data not shown).Carbonyl groups on proteins, CP
Pre-exercise concentrations of both groups were 15–
25% above normal (reference range < 200 pmol . mg-1).
There were no differences between groups at baseline.
The post-exercise increase was significant (P = 0.006).
Post-hoc analysis revealed that this exercise-induced in-
crease did not reach significance after 14 weeks of pro-
biotic treatment. After 14 weeks, the supplemented
group showed decreased CP concentrations pre and post
exercise compared to placebo, but likewise this effect
did not reach significance (P = 0.061) (Figure 3).Malondialdehyde, MDA
There were no differences between groups at any time
point assessed, neither with treatment nor with exercise.
MDA concentrations were unremarkable and within
normal range (2.16 ± 0.39 nmol . mL-1, data not shown).
n = 41 
Preselection via telephone 
screening 
n = 29 
Checked for eligibility 
(VO2max, blood panel etc.) 
n = 5 
Eliminated due to too low 
VO2max or too high body fat
n = 24 
Passed eligibility and 
RANDOMIZED 
n = 12 
Placebo 
n = 12 
Probiotics 
n = 12 
Completed study program 
n = 11 
Completed study program 
(drop out due to bone injury) 
Figure 1 CONSORT diagram.
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The measured TOS values were above normal at all
time points (reference range < 350 μmol . LH2O2
-1 ). As
with MDA, there were no differences between
groups at any time point assessed, neither with treat-
ment nor with exercise (data not shown).
Tumor necrosis factor alpha, TNF-α
Despite the typical high standard deviations for
TNF-α, due to well known cytokine inter-individual
variability, the data were normally distributed.Concentrations at all time points were distinctly
higher than normal (reference range < 20 pg . mL-1)
with mean values > 50 pg . mL-1 (Figure 4). After
14 weeks of probiotic supplementation, TNF-α
showed reduced concentrations compared to the pla-
cebo group but this effect barely failed significance
(P = 0.054). Exercise had no effect on TNF-α.
Interleukin 6, IL-6
There were no differences between groups at baseline
and after treatment. IL-6 concentrations were
Figure 2 Stool concentrations of zonulin in trained men before and after 14 weeks of treatment. Pro with probiotics supplemented
group, Plac placebo group, Tx treatment, wk week; n = 11 (probiotic supplementation), n = 12 (placebo). Values are means ± SD. There was a
signficant difference between groups after 14 wk of treatment: PTx < 0.05 (ANOVA).
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cise (< 11.3 pg . mL-1), but we observed a significant
increase from pre to post exercise above normal in
both groups (P = 0.001, Figure 5) at baseline and after
14 weeks of treatment.Figure 3 Plasma concentrations of carbonyl groups bounded on prot
pre/post a triple step test cycle ergometry. Pro with probiotics supplem
n= 11 (probiotic supplementation), n = 12 (placebo). Values are means ± SD
“Pro wk14”): PEx < 0.05; and a tendential difference between groups after 14Discussion
Athletes exposed to high intense exercise show increased
occurence of GI symptoms like cramps, diarrhea, bloating,
nausea, and bleeding [31,32]. These symptoms have been
associated with alterations in intestinal permeability andein in trained men before and after 14 weeks of treatment, and
ented group, Plac placebo group, Ex exercise, Tx treatment, wk week;
. There was a significant differences from pre to post exercise (except
wk of treatment: PTx < 0.1 (ANOVA).
Figure 4 Plasma concentrations of tumor necrosis factor-alpha in trained men before and after 14 weeks of treatment, and pre/post a
triple step test cycle ergometry. Pro with probiotics supplemented group, Plac placebo group, Tx treatment, wk week; n = 11 (probiotic
supplementation), n = 12 (placebo). Values are means ± SD. There was a tendential difference between groups after 14 wk of treatment:
PTx < 0.1 (ANOVA).
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flammation and oxidative stress [22,23].
For this investigation we assembled a panel of surro-
gate markers related to increased intestinal permeability,
oxidative stress and inflammation. The study wasFigure 5 Plasma concentrations of interleukin-6 in trained men befor
cycle ergometry. Pro with probiotics supplemented group, Plac placebo g
(placebo). Values are means ± SD. There were significant differences from pprimarily focussed on the effects of 14 weeks multi-
species probiotic supplementation on intestinal barrier
function in trained men compared to a placebo group
(primary outcome). The secondary outcome was to
evaluate the influence of the probiotic supplementatione and after 14 weeks of treatment, and pre/post a triple step test
roup, Ex exercise, wk week; n = 11 (probiotic supplementation), n = 12
re to post exercise: PEx < 0.05 (ANOVA).
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and inflammation. The resulting data show that, after
the 14 weeks study period i) the probiotics decreased
stool zonulin concentrations - a modulator of intestinal
barrier function - from slightly above normal into the
physiolgical range; ii) the probiotic supplementation
decreased protein oxidation and the chronic inflamma-
tory marker TNF-α; and iii) the model of exercise did
not induce oxidative stress but increased concentrations
of the inflammatory cytokine IL-6 in this cohort of en-
durance trained men.
Markers of intestinal permeability
Zonulin is regarded as a phyiological modulator of inter-
cellular tight junctions and a surrogate marker of
impaired gut barrier [19,35-37]. Beside liver cells, intes-
tinal cells can synthesize zonulin and the zonulin system
can be activated by dietary proteins (especially gliadin)
or enteric bacteria [21,38]. We can exclude a dietary in-
fluence on the observed changes in zonulin concentra-
tions as our subjects followed strictly all dietary
instructions and did not change their diet during the
study period. To our best knowledge this study reports
for the first time that probiotic supplementation can re-
duce zonulin concentrations in feces of trained men.
The observed reduction is all the more remarkable as
mean concentrations were slightly above normal at base-
line (ref. range: < 30 ng . mL-1) and decreased into nor-
mal after 14 weeks with probiotics. These data indicate
that our trained cohort suffered already a mild increase
in intestinal permeability at baseline, probably due to
chronic exercise training.
It seems that the 14 weeks of probiotic supplementa-
tion could reduce zonulin concentrations and hence
improve intestinal barrier integrity. A mechanistic ex-
planation for an improved intestinal barrier function
after probiotic treatment is provided by Karczewski et al.
[17]: they postulate that certain lactic bacteria might ac-
tivate the Toll-like receptor 2 (TLR2) signaling pathway.
TLR2 is localized in the membranes of intestinal wall
cells to communicate with metabolites and/or bricks
from e.g. Gram-positive bacteria [39]. Activation of the
TLR2 signaling pathway has been shown to enhance
epithelial resistance in vitro [40]. We suggest that the
supplemented probiotics surpassed bacteria that activate
the zonulin system (e.g. Gram-negative bacteria), settled
in the deep intestine, and could probably activate the
TLR2 signaling pathway. This hypothesis about the
settlement of the supplemented probiotic bacteria is in
part strengthened by observations of Koning et al. [41]
who showed that Enterococcus faecium W54 - one of
our used strains - significantly increases in feces after
2 weeks of multi-species probiotic treatment. Their find-
ings demonstrate that these bacteria can survive gastrictransport and colonize the GI tract. Thus, our observa-
tion on the zonulin decrease after probiotic supplemen-
tation could be of high practical relevance for athletes
under the perspective that an improved intestinal barrier
reduces athlete’s susceptibility to endotoxaemia and
associated cytokine production [42].
α1-antitrpysin in feces is another marker that displays
GI barrier integrity and is widely used to estimate pro-
tein leakage into the instestinal tract [43,44]. In this
study α1-antitrypsin values did not change after pro-
biotic treatment. We believe that, although our subjects
showed indices of a mild disturbance of intestinal per-
meability at baseline, this slight imbalance in intestinal
barrier function was not distinctive enough to provoke
an acute-phase response in liver cells via increased
α1-antitrypsin synthesis.
Oxidative stress markers
Protein oxidation can result in loss of enzyme and pro-
tein structur and function [45]. Reactive oxygen and
nitrogen species, free metal ions and lipid oxidation end
products can generate CP [46]. In this cohort, protein
oxidation, as indicated by CP, was already increased at
baseline in both groups. These data suggest a higher
level of protein oxidation in this group performing per-
manent physical exercise training. The increased resting
CP concentrations but also the post-exercise increase in
trained men of this age are not really surprising. We
already demonstrated that men under certain psycho-
physical stress profile can show increased protein oxida-
tion above normal at rest [47] and that high intense ex-
ercise also leads to increased CP [48]. The interesting
and new observation in this study was that CP concen-
trations decreased by a trend with probiotics and that
the post-exercise increase did not reach significance any-
more after probiotic treatment. Although only a trend,
we hypothesize that there could be a link between dis-
turbed intestinal barrier, probiotic supplementation and
protein oxidation. Some probiotic strains might exert
antioxidant activities that could beneficially influence
protein oxidation in plasma. Subsequent studies with a
higher number of subjects might help to investigate a
possible relation. It would be also interesting to observe
if a longer time period or higher dosages of probiotic
supplementation could lower CP values into a normal
range (reference range < 200 pmol . mg-1).
MDA, a widely used marker to estimate lipid peroxi-
dation [49-51], did not respond to probiotic supplemen-
tation. We measured bound MDA as an indicator of
older damage on PUFA [51]. However, we observed no
effect, indicating minor or no interaction of the nutra-
ceutical with this group of fatty acids.
TOS represents the amount of total lipid peroxides. It
is an all-over indicator of lipid peroxidation, and thus
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MDA. Values in both groups were above the reference
range (< 350 μmol . LH2O2
-1 ) at baseline and at the end of
the study. As for CP, these data indicate a higher level of
oxidation in this group under permanent physical exer-
cise training. However, in contrast to CP, this surrogate
marker was not influenced by the probiotic treatment.
Markers of inflammation
TNF-α is a pro-inflammatory cytokine and a central me-
diator of systemic inflammatory response. Leucocytes,
endothelium and adipocytes produce TNF-α but strenu-
ous exercise has only limited impact on its release, com-
pared to IL-6 [52]. This is also confirmed by our data
that did not show an exercise-induced effect on TNF-α
in both groups. Interestingly, our subjects showed sig-
nificant increased values above normal (reference
range < 20 pg . mL-1) at all measured time points. Pro-
biotic supplementation reduced these high values about
20% but this reduction did neither reach the normal
range nor significance (P = 0.054). However, our results
let us hypothesize that the trained men suffered a state
of chronic low-grade inflammation due to decreased in-
testinal barrier function which was likely evoked by
chronic exercise stress. The data indicate that there is a
potential for probiotic supplementation to reduce this
systemic low-grade inflammation indirectly via improve-
ment of gut barrier function.
In contrast to TNF-α, IL-6 is a cytokine which
increases significantly in plasma with strenuous exercise
as it originates primarily from the contracting sceletal
muscles [52]. During exercise the production of IL-6
seems to be a TNF-independent pathway [53]. We also
observed significantly increased IL-6 concentrations
after the strenuous exercise tests. The probiotic supple-
mentation had no influence on this IL-6 release. Obvi-
ously the exercise-induced, muscle-derived, increase in
IL-6 is not related to intestinal barrier integrity. This
suggestion is also supported by the normal IL-6 values
at rest and basline - in contrast to TNF-α. These normal
IL-6 values indicate that basic IL-6 production was not
affected by chronic exercise training or by the observed
mildly decreased gut barrier function.
Limitations of the study
We observed only trends for decreased TNF-alpha
(P = 0.054) and CP (P = 0.061) indicating that this study
was slightly underpowered for some outcomes. As we
did not find one study on zonulin and probiotic supple-
mentation in trained men to orientate, our sample size
calculation was based on CP and MDA and on our ex-
perience with enteral absorbed antioxidant concentrates
[48,50]. Obviously our assumptions for sample size cal-
culation cannot be drawn into account when probioticsupplements are used - at least with the study design
chosen in this project. Post hoc analysis revealed that 13
subjects per group for TNF-alpha and 15 subjects per
group for CP would have been enough to get significant
results. However, future studies with similar design
should consider a total sample size of at least 30 subjects
or a longer time period of treatment.
Another limitation of the study was the small number
of measured parameters. This study was primarily fo-
cused on the effects of probiotics on zonulin in trained
men. Subsequent studies should include a wider panel of
surrogate markers in stool and serum to raise options to
identify rationales and mechanisms. Parameters like
corticotropin- releasing hormone (CRH), indicating acti-
vation of mast cells that stimulate tight junctions, or
ß-hexosaminidase, several growth factors, an extended
range of cytokines as well as the assessment of different
fecal bacteria should be included.
Conclusions
In conclusion our data support the hypothesis that an
adequate probiotic supplementation can improve intes-
tinal barrier function, redox hemostasis and low-grade
inflammation in men under sustained exercise stress.
Subsequent studies that focus on leaky gut associated
consequences like endotoxaemia, athlete’s susceptibility
to inflammation, infections, and allergies will be of high
practical relevance.
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